Press release
Small Interfering RNA (siRNA) Therapeutics Market Research With Size, Growth, Key Players, Segments And Forecasts Analysis 2020-2026|GE, Horizon Discovery, Thermo Scientific
Key companies operating in the global Small Interfering RNA (siRNA) Therapeutics market include _GE, Horizon Discovery, Thermo Scientific, OPKO Health, AInylam Pharmaceuticals, Arrowhead Research, Sanofi Genzyme, Genecon Biotechnologies, Arbutus Biopharma, Silent Therapeutics, Sylentis
Get PDF Sample Copy of the Report to understand the structure of the complete report: (Including Full TOC, List of Tables & Figures, Chart) :
https://www.qyresearch.com/sample-form/form/1493546/global-small-interfering-rna-sirna-therapeutics-market
Segmental Analysis
The report has classified the global Small Interfering RNA (siRNA) Therapeutics industry into segments including product type and application. Every segment is evaluated based on growth rate and share. Besides, the analysts have studied the potential regions that may prove rewarding for the Small Interfering RNA (siRNA) Therapeutics manufcaturers in the coming years. The regional analysis includes reliable predictions on value and volume, thereby helping market players to gain deep insights into the overall Small Interfering RNA (siRNA) Therapeutics industry.
Global Small Interfering RNA (siRNA) Therapeutics Market Segment By Type:
Small, Liposome Based Systemic Therapy, Nanoparticle Based Systemic Therapy, Other
Global Small Interfering RNA (siRNA) Therapeutics Market Segment By Application:
Hospital, Research Institutions, Pharmaceutical and Biotechnology Companies, Academic Institutions, Other
Competitive Landscape
It is important for every market participant to be familiar with the competitive scenario in the global Small Interfering RNA (siRNA) Therapeutics industry. In order to fulfil the requirements, the industry analysts have evaluated the strategic activities of the competitors to help the key players strengthen their foothold in the market and increase their competitiveness.
Key companies operating in the global Small Interfering RNA (siRNA) Therapeutics market include _GE, Horizon Discovery, Thermo Scientific, OPKO Health, AInylam Pharmaceuticals, Arrowhead Research, Sanofi Genzyme, Genecon Biotechnologies, Arbutus Biopharma, Silent Therapeutics, Sylentis
Key questions answered in the report:
What is the growth potential of the Small Interfering RNA (siRNA) Therapeutics market?
Which product segment will grab a lion's share?
Which regional market will emerge as a frontrunner in coming years?
Which application segment will grow at a robust rate?
What are the growth opportunities that may emerge in Small Interfering RNA (siRNA) Therapeutics industry in the years to come?
What are the key challenges that the global Small Interfering RNA (siRNA) Therapeutics market may face in future?
Which are the leading companies in the global Small Interfering RNA (siRNA) Therapeutics market?
Which are the key trends positively impacting the market growth?
Which are the growth strategies considered by the players to sustain hold in the global Small Interfering RNA (siRNA) Therapeutics market?
Enquire Customization in The Report: https://www.qyresearch.com/customize-request/form/1493546/global-small-interfering-rna-sirna-therapeutics-market
TOC
Table of Contents 1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Small Interfering RNA (siRNA) Therapeutics Revenue
1.4 Market Analysis by Type
1.4.1 Global Small Interfering RNA (siRNA) Therapeutics Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Liposome Based Systemic Therapy
1.4.3 Nanoparticle Based Systemic Therapy
1.4.4 Other
1.5 Market by Application
1.5.1 Global Small Interfering RNA (siRNA) Therapeutics Market Share by Application: 2020 VS 2026
1.5.2 Hospital
1.5.3 Research Institutions
1.5.4 Pharmaceutical and Biotechnology Companies
1.5.5 Academic Institutions
1.5.6 Other 1.6 Study Objectives 1.7 Years Considered 2 Global Growth Trends by Regions
2.1 Small Interfering RNA (siRNA) Therapeutics Market Perspective (2015-2026)
2.2 Small Interfering RNA (siRNA) Therapeutics Growth Trends by Regions
2.2.1 Small Interfering RNA (siRNA) Therapeutics Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Small Interfering RNA (siRNA) Therapeutics Historic Market Share by Regions (2015-2020)
2.2.3 Small Interfering RNA (siRNA) Therapeutics Forecasted Market Size by Regions (2021-2026) 2.3 Industry Trends and Growth Strategy 2.3.1 Market Top Trends 2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter's Five Forces Analysis
2.3.5 Small Interfering RNA (siRNA) Therapeutics Market Growth Strategy
2.3.6 Primary Interviews with Key Small Interfering RNA (siRNA) Therapeutics Players (Opinion Leaders) 3 Competition Landscape by Key Players
3.1 Global Top Small Interfering RNA (siRNA) Therapeutics Players by Market Size
3.1.1 Global Top Small Interfering RNA (siRNA) Therapeutics Players by Revenue (2015-2020)
3.1.2 Global Small Interfering RNA (siRNA) Therapeutics Revenue Market Share by Players (2015-2020)
3.1.3 Global Small Interfering RNA (siRNA) Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Small Interfering RNA (siRNA) Therapeutics Market Concentration Ratio
3.2.1 Global Small Interfering RNA (siRNA) Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Small Interfering RNA (siRNA) Therapeutics Revenue in 2019
3.3 Small Interfering RNA (siRNA) Therapeutics Key Players Head office and Area Served
3.4 Key Players Small Interfering RNA (siRNA) Therapeutics Product Solution and Service
3.5 Date of Enter into Small Interfering RNA (siRNA) Therapeutics Market
3.6 Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type (2015-2026)
4.1 Global Small Interfering RNA (siRNA) Therapeutics Historic Market Size by Type (2015-2020)
4.2 Global Small Interfering RNA (siRNA) Therapeutics Forecasted Market Size by Type (2021-2026) 5 Small Interfering RNA (siRNA) Therapeutics Breakdown Data by Application (2015-2026)
5.1 Global Small Interfering RNA (siRNA) Therapeutics Market Size by Application (2015-2020)
5.2 Global Small Interfering RNA (siRNA) Therapeutics Forecasted Market Size by Application (2021-2026) 6 North America
6.1 North America Small Interfering RNA (siRNA) Therapeutics Market Size (2015-2020)
6.2 Small Interfering RNA (siRNA) Therapeutics Key Players in North America (2019-2020)
6.3 North America Small Interfering RNA (siRNA) Therapeutics Market Size by Type (2015-2020)
6.4 North America Small Interfering RNA (siRNA) Therapeutics Market Size by Application (2015-2020) 7 Europe
7.1 Europe Small Interfering RNA (siRNA) Therapeutics Market Size (2015-2020)
7.2 Small Interfering RNA (siRNA) Therapeutics Key Players in Europe (2019-2020)
7.3 Europe Small Interfering RNA (siRNA) Therapeutics Market Size by Type (2015-2020)
7.4 Europe Small Interfering RNA (siRNA) Therapeutics Market Size by Application (2015-2020) 8 China
8.1 China Small Interfering RNA (siRNA) Therapeutics Market Size (2015-2020)
8.2 Small Interfering RNA (siRNA) Therapeutics Key Players in China (2019-2020)
8.3 China Small Interfering RNA (siRNA) Therapeutics Market Size by Type (2015-2020)
8.4 China Small Interfering RNA (siRNA) Therapeutics Market Size by Application (2015-2020) 9 Japan
9.1 Japan Small Interfering RNA (siRNA) Therapeutics Market Size (2015-2020)
9.2 Small Interfering RNA (siRNA) Therapeutics Key Players in Japan (2019-2020)
9.3 Japan Small Interfering RNA (siRNA) Therapeutics Market Size by Type (2015-2020)
9.4 Japan Small Interfering RNA (siRNA) Therapeutics Market Size by Application (2015-2020) 10 Southeast Asia
10.1 Southeast Asia Small Interfering RNA (siRNA) Therapeutics Market Size (2015-2020)
10.2 Small Interfering RNA (siRNA) Therapeutics Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Small Interfering RNA (siRNA) Therapeutics Market Size by Type (2015-2020)
10.4 Southeast Asia Small Interfering RNA (siRNA) Therapeutics Market Size by Application (2015-2020) 11 India
11.1 India Small Interfering RNA (siRNA) Therapeutics Market Size (2015-2020)
11.2 Small Interfering RNA (siRNA) Therapeutics Key Players in India (2019-2020)
11.3 India Small Interfering RNA (siRNA) Therapeutics Market Size by Type (2015-2020)
11.4 India Small Interfering RNA (siRNA) Therapeutics Market Size by Application (2015-2020) 12 Central & South America
12.1 Central & South America Small Interfering RNA (siRNA) Therapeutics Market Size (2015-2020)
12.2 Small Interfering RNA (siRNA) Therapeutics Key Players in Central & South America (2019-2020)
12.3 Central & South America Small Interfering RNA (siRNA) Therapeutics Market Size by Type (2015-2020)
12.4 Central & South America Small Interfering RNA (siRNA) Therapeutics Market Size by Application (2015-2020) 13Key Players Profiles
13.1 GE
13.1.1 GE Company Details
13.1.2 GE Business Overview and Its Total Revenue
13.1.3 GE Small Interfering RNA (siRNA) Therapeutics Introduction
13.1.4 GE Revenue in Small Interfering RNA (siRNA) Therapeutics Business (2015-2020))
13.1.5 GE Recent Development
13.2 Horizon Discovery
13.2.1 Horizon Discovery Company Details
13.2.2 Horizon Discovery Business Overview and Its Total Revenue
13.2.3 Horizon Discovery Small Interfering RNA (siRNA) Therapeutics Introduction
13.2.4 Horizon Discovery Revenue in Small Interfering RNA (siRNA) Therapeutics Business (2015-2020)
13.2.5 Horizon Discovery Recent Development
13.3 Thermo Scientific
13.3.1 Thermo Scientific Company Details
13.3.2 Thermo Scientific Business Overview and Its Total Revenue
13.3.3 Thermo Scientific Small Interfering RNA (siRNA) Therapeutics Introduction
13.3.4 Thermo Scientific Revenue in Small Interfering RNA (siRNA) Therapeutics Business (2015-2020)
13.3.5 Thermo Scientific Recent Development
13.4 OPKO Health
13.4.1 OPKO Health Company Details
13.4.2 OPKO Health Business Overview and Its Total Revenue
13.4.3 OPKO Health Small Interfering RNA (siRNA) Therapeutics Introduction
13.4.4 OPKO Health Revenue in Small Interfering RNA (siRNA) Therapeutics Business (2015-2020)
13.4.5 OPKO Health Recent Development
13.5 AInylam Pharmaceuticals
13.5.1 AInylam Pharmaceuticals Company Details
13.5.2 AInylam Pharmaceuticals Business Overview and Its Total Revenue
13.5.3 AInylam Pharmaceuticals Small Interfering RNA (siRNA) Therapeutics Introduction
13.5.4 AInylam Pharmaceuticals Revenue in Small Interfering RNA (siRNA) Therapeutics Business (2015-2020)
13.5.5 AInylam Pharmaceuticals Recent Development
13.6 Arrowhead Research
13.6.1 Arrowhead Research Company Details
13.6.2 Arrowhead Research Business Overview and Its Total Revenue
13.6.3 Arrowhead Research Small Interfering RNA (siRNA) Therapeutics Introduction
13.6.4 Arrowhead Research Revenue in Small Interfering RNA (siRNA) Therapeutics Business (2015-2020)
13.6.5 Arrowhead Research Recent Development
13.7 Sanofi Genzyme
13.7.1 Sanofi Genzyme Company Details
13.7.2 Sanofi Genzyme Business Overview and Its Total Revenue
13.7.3 Sanofi Genzyme Small Interfering RNA (siRNA) Therapeutics Introduction
13.7.4 Sanofi Genzyme Revenue in Small Interfering RNA (siRNA) Therapeutics Business (2015-2020)
13.7.5 Sanofi Genzyme Recent Development
13.8 Genecon Biotechnologies
13.8.1 Genecon Biotechnologies Company Details
13.8.2 Genecon Biotechnologies Business Overview and Its Total Revenue
13.8.3 Genecon Biotechnologies Small Interfering RNA (siRNA) Therapeutics Introduction
13.8.4 Genecon Biotechnologies Revenue in Small Interfering RNA (siRNA) Therapeutics Business (2015-2020)
13.8.5 Genecon Biotechnologies Recent Development
13.9 Arbutus Biopharma
13.9.1 Arbutus Biopharma Company Details
13.9.2 Arbutus Biopharma Business Overview and Its Total Revenue
13.9.3 Arbutus Biopharma Small Interfering RNA (siRNA) Therapeutics Introduction
13.9.4 Arbutus Biopharma Revenue in Small Interfering RNA (siRNA) Therapeutics Business (2015-2020)
13.9.5 Arbutus Biopharma Recent Development
13.10 Silent Therapeutics
13.10.1 Silent Therapeutics Company Details
13.10.2 Silent Therapeutics Business Overview and Its Total Revenue
13.10.3 Silent Therapeutics Small Interfering RNA (siRNA) Therapeutics Introduction
13.10.4 Silent Therapeutics Revenue in Small Interfering RNA (siRNA) Therapeutics Business (2015-2020)
13.10.5 Silent Therapeutics Recent Development
13.11 Sylentis
10.11.1 Sylentis Company Details
10.11.2 Sylentis Business Overview and Its Total Revenue
10.11.3 Sylentis Small Interfering RNA (siRNA) Therapeutics Introduction
10.11.4 Sylentis Revenue in Small Interfering RNA (siRNA) Therapeutics Business (2015-2020)
10.11.5 Sylentis Recent Development 14Analyst's Viewpoints/Conclusions 15Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Contact US:
QY Research, INC.
17890 Castleton,
Suite 218,
City of industry, CA - 91748
USA: +1 626 295 2442
Email: enquiry@qyresearch.com
Web: http://www.qyresearch.com
About Us:
QYResearch always pursuits high product quality with the belief that quality is the soul of business. Through years of effort and supports from huge number of customer supports, QYResearch consulting group has accumulated creative design methods on many high-quality markets investigation and research team with rich experience. Today, QYResearch has become the brand of quality assurance in consulting industry.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Small Interfering RNA (siRNA) Therapeutics Market Research With Size, Growth, Key Players, Segments And Forecasts Analysis 2020-2026|GE, Horizon Discovery, Thermo Scientific here
News-ID: 1994630 • Views: …
More Releases from QY Research, Inc
Global High Pressure Commercial Toilet Market Insights - Industry Share, Sales P …
High Pressure Commercial Toilet also means pressure-flushing toilets. Pressure-flushing toilets are especially common in cities in the U.S. The ceramic tank is not used as a water tank. It holds a plastic pressure vessel of maybe one-third to one-half the ceramic tank"s volume. That pressure tank contains a sealed air bladder. When the tank is filled from the water supply line, the tank fills with water until the air bladder…
Global Twin-Screw Pumps Market Insights - Industry Share, Sales Projections, and …
Twin-Screw Pumps is a displacement pump consisting of a casing containing two parallel screws with intermeshing threads fitted to prevent backward movement of fluid
The global Twin-Screw Pumps market was valued at US$ 503 million in 2023 and is anticipated to reach US$ 629 million by 2030, witnessing a CAGR of 3.3% during the forecast period 2024-2030.
The top five global producers of twin-screw pumps are Colfax, ITT Bornemann, Flowserve, SPX Flow…
Global Strain Gauge Sensors Market Insights - Industry Share, Sales Projections, …
A strain gauge (or strain gage) is a sensor whose resistance varies with applied force; it converts force, pressure, tension, weight, etc., into a change in electrical resistance which can then be measured. When external forces are applied to a stationary object, stress and strain are the result. Stress is defined as the object"s internal Strain Gauge forces, and strain is defined as the displacement and deformation that occur.
The global…
Global Automatic Soap Dispensers Market Insights - Industry Share, Sales Project …
Automatic soap dispensers (also known as touchless or no-touch soap dispensers) dispense a controlled amount of soap solution (or a similar liquid such as a hand sanitizer). They are often used in conjunction with automatic faucets in public restrooms. They function to conserve the amount of soap used and stem infectious disease transmission.
The global Automatic Soap Dispensers market was valued at US$ million in 2023 and is anticipated to reach…
More Releases for RNA
CD Formulation Launches Custom Circular RNA Synthesis Service to Accelerate RNA …
CD Formulation introduces a customizable circRNA synthesis service, delivering high-quality, stable circRNAs for therapeutics, vaccines, and gene research, supported by advanced design and QC processes.
CD Formulation, a leading provider of advanced small nucleic acid synthesis [https://www.formulationbio.com/nucleic-acid/custom-small-nucleic-acid-synthesis.html] solutions, is proud to announce the launch of its fully customizable circular RNA (circRNA) synthesis service. This new service addresses the growing need for stable, non-immunogenic RNA molecules for therapeutic development, vaccine research, and…
Self-Amplifying RNA Synthesis Market Gains Traction as Biotech Firms Embrace Sca …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the " Self-Amplifying RNA Synthesis Market- (By Product & Service (Products (Enzymes & Reagents, Premade saRNA, Others), Custom Synthesis Services), By Application (Therapeutics Development (Oncology, Infectious Diseases, Others), Biomedical Research), By End-User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Others)), Trends, Industry Competition Analysis, Revenue and Forecast To 2034."
According to the latest research by InsightAce Analytic,…
RNA Extraction and RNA Purification Market: Growth, Trends & Competitive Landsca …
The global RNA Extraction and RNA Purification Market is expected to grow at 6.3% CAGR from 2025 to 2032.
This Market Report is the result of extensive research and analysis conducted by our team of experienced market researchers through -
• 70% efforts of Primary Research
• 15% efforts of Secondary Research
• 15% efforts from the subscription to Paid database providing industry overview, macro and micro economics factors, and financials of private limited…
RNA Targeting Small Molecules Therapeutics Market: Exponential Growth with Risin …
Estimations Predict a CAGR of 29.8% by 2029 in Global RNA Targeting Small Molecules Therapeutics Market Boosted by Precision Medicine, RNA Biomarker Identification and RNA Genetic Manipulation
What Is The Projected Market Size of The Global RNA Targeting Small Molecules Therapeutics Market And Its Growth Rate?
• The market will grow from $6.1 billion in 2024 to $7.87 billion in 2025 at a compound annual growth rate (CAGR) of 28.9%.
• Expected exponential…
Global DNARNA Extraction Kit Market by Type (Cell-free DNA (cfDNA), Sequence-spe …
"DNARNA Extraction Kit Market" is segmented by Company, Region (country), By Type, Application, stakeholders and other participants. This report provides an analysis of revenue and forecast across Type and Application segments for 2023-2032.
The market for DNARNA Extraction Kits has been thoroughly researched via primary and secondary sources to produce this research study. Along with a competitive analysis of the market, segmented by application, type, and geographical trends, it offers a…
Cancer RNA Expression Market to Reap Excessive Revenues by 2028(By sequencing te …
Worldwide cancer is one of the leading cause of death and effective way of treating it still looks unaccomplished in most parts of the world. The factors which influence the successful treatment of cancer are different depending on the stage of diagnosis, treatment availability and availability of trained healthcare professionals coupled with high economic burden of the disease. The gene expression of cancerous cells varies by cancer type and may…
